Syridex Bio

Life sciences executive advising pharmaceutical, biotech, and medical device companies on FDA regulatory, legal, and global compliance matters, having served as Chief Legal Officer and Chief Compliance Officer and as Chair of Baker McKenzie's North America Food and Drug Practice. She holds a J.D. from the University of South Carolina and a B.A. from Hampton University.

Physician-scientist and Principal at Syridex Bio with over a decade of healthcare experience as a maxillofacial surgeon and public health practitioner. He was previously Senior Associate at Adjuvant Capital and holds an MD/dental degree, a Harvard MPH, and a Stanford MBA.

Former Partner and Head of Deal Advisory at KPMG with over 30 years of global transaction experience. He currently serves as a Program Partner at The Hashgraph Association and holds accounting/management qualifications and an economics degree from Presidency College, Calcutta University.

Founder and CEO of Cormorant IV Corporation, a consulting firm specializing in operational turnarounds and organizational transformations, with 30 years of Wall Street M&A and advisory experience. He is a graduate of Yale and holds an MBA and JD from Harvard.

Private equity investor with decades of Wall Street experience, most recently Senior Managing Director and Head of Investments for Ariel Alternatives and Project Black. He is a graduate of Princeton with an MBA from Columbia Business School.

Biopharmaceutical executive with 30+ years of senior leadership experience, most recently as Executive Director and Regional General Manager of Africa at Gilead Sciences. He previously founded several healthcare companies and was CEO of Eli Lilly South Africa. He holds a BA from Wabash College and an MBA from Duke.

Serial entrepreneur and attorney with 35+ years in life sciences, having co-founded multiple pharmaceutical and biopharmaceutical companies that raised over a billion dollars. She serves on the boards of two NASDAQ-listed biotech companies and holds a J.D. from Harvard Law and a B.A. from Princeton.

Founder and CEO of May Davis Partners, an investment bank and advisory practice, with 30+ years of experience in M&A, corporate finance, IPOs, and business turnarounds. He holds an MBA from Duke and a B.S. in biology from the University of Miami.

Executive and subject matter expert in Health Economics and Outcomes Research (HEOR) and market access, currently driving portfolio optimization at J&J MedTech and formerly Executive Director at Eli Lilly. She holds a PhD in Pharmacy from The Ohio State University.

Former President & CEO of Global Blood Therapeutics and current Chair of the Board of the Biotechnology Industry Association (BIO), with over two decades of biopharmaceutical leadership at companies including Onyx, Nuvelo, and Genentech. He holds a B.A. from Haverford and an M.D. from Yale Medical School.